Literature DB >> 28292814

Critical international normalized ratio results after hours: To call or not to call?

Darlene Korn1, M Sean McMurtry2, Kirsten George-Phillips3, Tammy J Bungard4.   

Abstract

OBJECTIVE: To determine whether the timing of notification of critical international normalized ratio (INR) results (during or after clinic hours) altered the clinician's ability to affect same-day patient care.
DESIGN: Retrospective chart review.
SETTING: The Anticoagulation Management Service at the University of Alberta Hospital in Edmonton. PARTICIPANTS: A total of 276 patients with critical INR results (> 5.0) separated by at least 30 days were identified to have 200 critical INR results reported during clinic hours and 200 reported after hours. MAIN OUTCOME MEASURES: Differences in the proportion of patients with critical INR results having same-day care altered (by changing warfarin dose, administering vitamin K, or referring for assessment) between those with results reported during clinic hours compared with those with results reported after clinic hours. Differences by highly critical INR results (> 9.0 vs ≤ 9.0) and whether patients experienced thromboembolism or bleeding within 30 days were also assessed.
RESULTS: Same-day patient care was affected for 174 out of 200 (87.0%) critical INR results reported during clinic hours compared with 101 out of 200 (50.5%) reported after clinic hours (P < .001). The most common reason for not being able to intervene was that warfarin had already been taken. Warfarin dose alteration was the most frequent change (97.1% during clinic hours and 96.0% after hours). When patients with INRs greater than 9.0 were assessed separately, the ability to affect care increased for INRs reported both during and after clinic hours (92.9% and 63.6%, respectively), largely attributable to oral vitamin K use. Overall, thromboembolic and major bleeding event rates were low and were similar in both groups.
CONCLUSION: Same-day care was less likely to be affected by critical INR results communicated after hours, most commonly because the patient had already taken their daily warfarin dose. However, after-hours care was still affected for 1 out of 2 patients, which is meaningful and supports current practice. Copyright© the College of Family Physicians of Canada.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28292814      PMCID: PMC5349737     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Anticoagulation management services: entering a new era.

Authors:  Edith A Nutescu
Journal:  Pharmacotherapy       Date:  2010-04       Impact factor: 4.705

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Authors:  E M Hylek; Y C Chang; S J Skates; R A Hughes; D E Singer
Journal:  Arch Intern Med       Date:  2000-06-12

5.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

6.  Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care.

Authors:  Tammy J Bungard; Leslie Gardner; Stephen L Archer; Peter Hamilton; Bruce Ritchie; Wayne Tymchak; Ross T Tsuyuki
Journal:  Open Med       Date:  2009-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.